Multisystem inflammatory syndrome in 1.2 million children: longitudinal cohort study of risk factors

Abstract

Background: We identified patient characteristics associated with an increased risk of developing MIS-C. Methods: We conducted a longitudinal cohort study of 1,195,327 patients aged 0–19 years between 2006 and 2021, including the first two waves of the pandemic (February 25–August 22, 2020 and August 23, 2020-March 31, 2021). Exposures included prepandemic morbidity, birth outcomes, and family history of maternal disorders. Outcomes included MIS-C, Kawasaki disease, and other Covid-19 complications during the pandemic. We calculated risk ratios (RRs) and 95% confidence intervals (CIs) for the association between patient exposures and these outcomes using log-binomial regression models adjusted for potential confounders. Results: Among 1,195,327 children, 84 developed MIS-C, 107 Kawasaki disease, and 330 other Covid-19 complications during the first year of the pandemic. Prepandemic hospitalizations for metabolic disorders (RR 11.3, 95% CI 5.61–22.6), atopic conditions (RR 3.34, 95% CI 1.60–6.97), and cancer (RR 8.11, 95% CI 1.13–58.3) were strongly associated with the risk of MIS-C, compared with no exposure. These same exposures were also associated with Kawasaki disease and other Covid-19 complications. However, birth characteristics and history of maternal morbidity were not associated with MIS-C development. Conclusions: Children with pre-existing morbidity have a considerably elevated risk of MIS-C. Impact: Morbidities that predispose children to multisystem inflammatory syndrome (MIS-C) are unclear.In this study, prepandemic hospitalizations for metabolic disorders, atopic conditions, and cancer were associated with an elevated risk of MIS-C.Birth characteristics and family history of maternal morbidity were not, however, associated with MIS-C.Pediatric morbidities may play a greater role in MIS-C onset than maternal or perinatal characteristics, and may help clinicians better recognize children at risk for this complication.